-
Je něco špatně v tomto záznamu ?
NOX4-reactive oxygen species axis: critical regulators of bone health and metabolism
M. Dzubanova, JM. Bond, SM. Craige, M. Tencerova
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
K01 AR073332
NIAMS NIH HHS - United States
NLK
Directory of Open Access Journals
od 2013
Free Medical Journals
od 2013
PubMed Central
od 2013
Europe PubMed Central
od 2013
Open Access Digital Library
od 2013-01-01
Open Access Digital Library
od 2013-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2013
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Bone marrow stromal cells (BMSCs) play a significant role in bone metabolism as they can differentiate into osteoblasts, bone marrow adipocytes (BMAds), and chondrocytes. BMSCs chronically exposed to nutrient overload undergo adipogenic programming, resulting in bone marrow adipose tissue (BMAT) formation. BMAT is a fat depot transcriptionally, metabolically, and morphologically distinct from peripheral adipose depots. Reactive oxygen species (ROS) are elevated in obesity and serve as important signals directing BMSC fate. ROS produced by the NADPH oxidase (NOX) family of enzymes, such as NOX4, may be responsible for driving BMSC adipogenesis at the expense of osteogenic differentiation. The dual nature of ROS as both cellular signaling mediators and contributors to oxidative stress complicates their effects on bone metabolism. This review discusses the complex interplay between ROS and BMSC differentiation in the context of metabolic bone diseases.Special attention is paid to the role of NOX4-ROS in regulating cellular processes within the bone marrow microenvironment and potential target in metabolic bone diseases.
Faculty of Science Charles University Prague Czechia
Human Nutrition Foods and Exercise Virginia Tech Blacksburg VA United States
Translational Biology Medicine and Health Virginia Tech Roanoke VA United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018051
- 003
- CZ-PrNML
- 005
- 20241016081941.0
- 007
- ta
- 008
- 241008e20240812sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fcell.2024.1432668 $2 doi
- 035 __
- $a (PubMed)39188529
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Dzubanova, Martina $u Laboratory of Molecular Physiology of Bone, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia $u Faculty of Science, Charles University, Prague, Czechia
- 245 10
- $a NOX4-reactive oxygen species axis: critical regulators of bone health and metabolism / $c M. Dzubanova, JM. Bond, SM. Craige, M. Tencerova
- 520 9_
- $a Bone marrow stromal cells (BMSCs) play a significant role in bone metabolism as they can differentiate into osteoblasts, bone marrow adipocytes (BMAds), and chondrocytes. BMSCs chronically exposed to nutrient overload undergo adipogenic programming, resulting in bone marrow adipose tissue (BMAT) formation. BMAT is a fat depot transcriptionally, metabolically, and morphologically distinct from peripheral adipose depots. Reactive oxygen species (ROS) are elevated in obesity and serve as important signals directing BMSC fate. ROS produced by the NADPH oxidase (NOX) family of enzymes, such as NOX4, may be responsible for driving BMSC adipogenesis at the expense of osteogenic differentiation. The dual nature of ROS as both cellular signaling mediators and contributors to oxidative stress complicates their effects on bone metabolism. This review discusses the complex interplay between ROS and BMSC differentiation in the context of metabolic bone diseases.Special attention is paid to the role of NOX4-ROS in regulating cellular processes within the bone marrow microenvironment and potential target in metabolic bone diseases.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bond, Jacob M $u Translational Biology, Medicine, and Health, Virginia Tech, Roanoke, VA, United States
- 700 1_
- $a Craige, Siobhan M $u Human Nutrition, Foods and Exercise, Virginia Tech, Blacksburg, VA, United States
- 700 1_
- $a Tencerova, Michaela $u Laboratory of Molecular Physiology of Bone, Institute of Physiology of the Czech Academy of Sciences, Prague, Czechia
- 773 0_
- $w MED00186212 $t Frontiers in cell and developmental biology. $x 2296-634X $g Roč. 12 (20240812), s. 1432668
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39188529 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241008 $b ABA008
- 991 __
- $a 20241016081936 $b ABA008
- 999 __
- $a ok $b bmc $g 2196444 $s 1230002
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2024 $b 12 $c - $d 1432668 $e 20240812 $i 2296-634X $m Frontiers in cell and developmental biology. $n Front Cell Dev Biol $x MED00186212
- GRA __
- $a K01 AR073332 $p NIAMS NIH HHS $2 United States
- LZP __
- $a Pubmed-20241008